TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34529781

Group type: EXPERIMENTAL
Intervention: Intravenous loop diuretics
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Protocol-driven intensified diuretic therapies (n = 43)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Diuretic-induced natriuresis
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Pre-diuretic urine sodium to creatinine ratio
Number of subjects: 285
Study: 35113639

Group type: EXPERIMENTAL
Intervention: Emotion-Focused Therapy (EFT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 58
Study: 33051759

Group type: EXPERIMENTAL
Intervention: Advanced laparoscopic curriculum (ALC) training
Number of subjects: 25

Group type: COMPARATOR
Intervention: FLS training (control group)
Number of subjects: 25
Study: 33971933

Group type: EXPERIMENTAL
Intervention: Add‐Aspirin trial with EHR data from NCRAS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PATCH trial with EHR data from NICOR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PATCH trial with EHR data from NHS Digital
Number of subjects: 0
Study: 35796209

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NT-proBNP and hs-cTnT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk score model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risk score model for HF hospitalization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mortality risk model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External validation of risk models
Number of subjects: 0
Study: 33772443

Group type: EXPERIMENTAL
Intervention: PRECISE model (with ECG)
Number of subjects: 1658

Group type: COMPARATOR
Intervention: Duke Clinical Score (DCS)
Number of subjects: 1658

Group type: COMPARATOR
Intervention: CAD Consortium Score (CCS-basic)
Number of subjects: 1658

Group type: COMPARATOR
Intervention: CAD Consortium Score (CCS-clinical)
Number of subjects: 1658

Group type: COMPARATOR
Intervention: Marburg Heart Score (MHS)
Number of subjects: 1658
Study: 32710304

Group type: EXPERIMENTAL
Intervention: Ultrasound group (surfactant based on LUS score and/or FiO2 threshold)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (guided by FiO2 only)
Number of subjects: 56
Study: 35365511

Group type: EXPERIMENTAL
Intervention: Surgical treatment (open reduction and internal fixation)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Non-operative treatment (closed reduction followed by cast treatment)
Number of subjects: 154
Study: 33236211

Group type: EXPERIMENTAL
Intervention: Decongestive lymphatic treatment (DLT) consisting of an intensive treatment phase of 3 weeks, followed by a maintenance treatment phase of 6 months.
Number of subjects: 194
Study: 36463113

Group type: EXPERIMENTAL
Intervention: Myopia Master
Number of subjects: 125

Group type: COMPARATOR
Intervention: IOLMaster 500
Number of subjects: 125

Group type: COMPARATOR
Intervention: IOLMaster 700
Number of subjects: 125

Group type: COMPARATOR
Intervention: Manifest refraction
Number of subjects: 125
Study: 37873691

Group type: EXPERIMENTAL
Intervention: Hamstring autograft
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterior tibialis allograft
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall average tibial slope of nonfailure cohort
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall average tibial slope of failure cohort
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Average slope of allograft failures
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Average slope of autograft failures
Number of subjects: 100
Study: 34105695

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A) injections
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Acupuncture (AC)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Saline solution (SS)
Number of subjects: 54
Study: 32343963

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Lifestyle modification (control group)
Number of subjects: 98
Study: 32744951

Group type: EXPERIMENTAL
Intervention: Ceramics intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Storytelling intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (wait 12 weeks)
Number of subjects: 0
Study: 32443744

Group type: EXPERIMENTAL
Intervention: Pilates group (PG, n = 55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (CG, n = 55)
Number of subjects: 110
Study: 35513977

Group type: EXPERIMENTAL
Intervention: Sleep restriction (experimental group)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Typical sleep (control group)
Number of subjects: 46
Study: 33832641

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Moderate adherence
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: High adherence
Number of subjects: 172
Study: 35901188

Group type: EXPERIMENTAL
Intervention: Volitional Help Sheet (VHS)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Empathy Inductions (EI)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Behavioral Journalism (BJ)
Number of subjects: 424
Study: 34422049

Group type: EXPERIMENTAL
Intervention: Apatinib combined with chemotherapy
Number of subjects: 74

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 74
Study: 34058423

Group type: EXPERIMENTAL
Intervention: Prophylactic negative-pressure wound therapy device
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard surgical dressing
Number of subjects: 110
Study: 35312891

Group type: EXPERIMENTAL
Intervention: Tablet-based patient education tool
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 229
Study: 32598060

Group type: EXPERIMENTAL
Intervention: Dressing with the addition of a skin barrier film
Number of subjects: 185

Group type: COMPARATOR
Intervention: Standard wound dressing (control group)
Number of subjects: 185
Study: 35160103

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention for 28 days
Number of subjects: 124

Group type: COMPARATOR
Intervention: No exercise intervention for 28 days (control)
Number of subjects: 124
Study: 32338345

Group type: EXPERIMENTAL
Intervention: Single-dose apalutamide 240 mg
Number of subjects: 68
Study: 35317414

Group type: EXPERIMENTAL
Intervention: SQ‐LNS (130 µg selenium/20 g)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MMN (130 µg selenium per capsule)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IFA (iron and folic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SQ‐LNS
Number of subjects: 0
Study: 32771032

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Phosphate/Sulfate (200 mg orally 8 hourly thrice a day for 5 days)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg orally twice a day for 5 days)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg orally daily on day 1, followed by 250 mg orally twice a day on days 2‐5)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Combination of Hydroxychloroquine and Oseltamivir
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Combination of Hydroxychloroquine and Azithromycin
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Combination of Oseltamivir and Azithromycin
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Triple drug regimen (Hydroxychloroquine, Oseltamivir, and Azithromycin)
Number of subjects: 470
Study: 35351329

Group type: EXPERIMENTAL
Intervention: Vocal demand (reading aloud for 1 hour at 85-90 dB)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (no vocal demand tasks)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Vocal demand
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 36123937

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS) nursing intervention in laparotomy (Group A2, n=34)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS) nursing intervention in laparoscopic surgery (Group B2, n=32)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Traditional nursing in laparotomy (Group A1, n=33)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Traditional nursing in laparoscopic surgery (Group B1, n=31)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Fast-track surgery (FTS) nursing intervention
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Simultaneous implementation of FTS and laparoscopic surgery
Number of subjects: 130
Study: 34528576

Group type: EXPERIMENTAL
Intervention: Rucaparib (maintenance therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 33124177

Group type: EXPERIMENTAL
Intervention: Punctoplasty
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Dacrocystorhinostomy with retrograde intubation (R-DCR)
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: R-DCR
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Trephination
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Monocanalicular intubation
Number of subjects: 775

Group type: EXPERIMENTAL
Intervention: Canaliculodacryocystorhinostomy (CDCR)
Number of subjects: 775

Group type: COMPARATOR
Intervention: StopLoss Jones tubes (SLJT)
Number of subjects: 775
Study: 33372679

Group type: EXPERIMENTAL
Intervention: 200 mg/d resveratrol
Number of subjects: 52

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 52
Study: 35342036

Group type: EXPERIMENTAL
Intervention: Positive Psychology Intervention (PPI)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 84
Study: 32070353

Group type: EXPERIMENTAL
Intervention: Simulation-based mastery learning (SBML) via the Uncertainty Communication Education Module (UCEM), which includes a web-based interactive module and a smartphone-based game, followed by remote deliberate practice sessions.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed receipt of the Uncertainty Communication Education Module (UCEM) after the second study visit.
Number of subjects: 0
Study: 36403208

Group type: EXPERIMENTAL
Intervention: Partial Pulpotomy (PP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Full Pulpotomy (FP)
Number of subjects: 50
Study: 33797018

Group type: EXPERIMENTAL
Intervention: Occluded non-ventilated lumen during OLV
Number of subjects: 30

Group type: COMPARATOR
Intervention: Open non-ventilated lumen during OLV (control group)
Number of subjects: 30
Study: 33423824

Group type: EXPERIMENTAL
Intervention: Diazepam (DZP), doses 5–20 mg IV
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dexmedetomidine (DEX), infusion 2–7 mcg/kg/min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dexmedetomidine (DEX)
Number of subjects: 40
Study: 33540351

Group type: EXPERIMENTAL
Intervention: IG-1 (face-to-face)
Number of subjects: 245

Group type: COMPARATOR
Intervention: CG (control group)
Number of subjects: 245
Study: 35108604

Group type: EXPERIMENTAL
Intervention: Single-session behavioural intervention combining childbirth-related reminder cues with a visuospatial task
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Single-session behavioural intervention
Number of subjects: 18
Study: 34282160

Group type: COMPARATOR
Intervention: Obstetric hemorrhage risk assessment tool (low-risk group)
Number of subjects: 56903

Group type: COMPARATOR
Intervention: Obstetric hemorrhage risk assessment tool (medium-risk group)
Number of subjects: 56903

Group type: COMPARATOR
Intervention: Obstetric hemorrhage risk assessment tool (high-risk group)
Number of subjects: 56903

Group type: COMPARATOR
Intervention: Medium- and high-risk groups compared to low-risk group
Number of subjects: 56903
Study: 34349013

Group type: EXPERIMENTAL
Intervention: Balloon-mounted stent (BMS)
Number of subjects: 232
Study: 32830552

Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 16
Study: 32560705

Group type: EXPERIMENTAL
Intervention: PHQ-4 screening scale
Number of subjects: 2426
Study: 36244275

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham Dry Needling (Sham-DN)
Number of subjects: 46
Study: 32554198

Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR)
Number of subjects: 2419

Group type: COMPARATOR
Intervention: Open Surgical Repair (OSR)
Number of subjects: 2419
Study: 36017782

Group type: EXPERIMENTAL
Intervention: Single-day dexamethasone (DEX)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Multiple-day dexamethasone (DEX) plus palonosetron and NK-1 receptor antagonists (NK-1RAs)
Number of subjects: 242
Study: 33940867

Group type: COMPARATOR
Intervention: Visual condition with a blank silhouette
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual condition with a European face
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual condition with an East Asian face
Number of subjects: 0

Group type: COMPARATOR
Intervention: Visual condition with a South Asian face
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-native accent perception
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correct perception of Chinese-accented speech
Number of subjects: 0
Study: 35660990

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg/day
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Clonazepam 1 mg/day
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg/day
Number of subjects: 93
Study: 33899642

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF) treatment
Number of subjects: 0
Study: 32720618

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (previous hypoglycemic therapy)
Number of subjects: 40
Study: 36145177

Group type: EXPERIMENTAL
Intervention: 25 mg choline/d
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 550 mg choline/d
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Variant maternal PEMT rs4646343 genotypes
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Variant maternal MTHFD1 rs2235226 genotypes
Number of subjects: 30
Study: 34303034

Group type: EXPERIMENTAL
Intervention: CARA breast support
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 30
Study: 33568556

Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg every 4 weeks (Q4W)
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: guselkumab 100 mg at Week0, Week4, then Q8W
Number of subjects: 381

Group type: EXPERIMENTAL
Intervention: guselkumab (both Q4W and Q8W)
Number of subjects: 381

Group type: COMPARATOR
Intervention: guselkumab Q4W
Number of subjects: 381

Group type: COMPARATOR
Intervention: guselkumab Q8W
Number of subjects: 381

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 381
Study: 32501276

Group type: EXPERIMENTAL
Intervention: Healthy lifestyle psychoeducational program (HLP)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MP)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Focused program on positive affect promotion (PAPP)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control condition (improved treatment as usual - iTAU)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: All low-intensity psychological interventions (HLP, MP, PAPP)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: PAPP
Number of subjects: 221
Study: 36171028

Group type: EXPERIMENTAL
Intervention: +Stay Active intervention (smartphone application combined with motivational interviewing)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: +Stay Active intervention
Number of subjects: 60
Study: 34404467

Group type: EXPERIMENTAL
Intervention: tDCS (anodal)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 73
Study: 33871218

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (20 mg/day for 12 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 34428592

Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 140

Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 140
Study: 34251458

Group type: EXPERIMENTAL
Intervention: Total FORTA score ≥ 7
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: FORTA sub-scores for PIM use and overuse
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: Total FORTA and potentially inappropriate medication score
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: Men and rectal cancer patients
Number of subjects: 3239
Study: 32007513

Group type: EXPERIMENTAL
Intervention: Serlopitant 5 mg daily for 8 weeks
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Serlopitant 5 mg
Number of subjects: 204
Study: 35379538

Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance exercise program
Number of subjects: 99

Group type: COMPARATOR
Intervention: Routine prenatal care, online education, and personalized diabetes diet intervention (Control)
Number of subjects: 99
Study: 34339456

Group type: EXPERIMENTAL
Intervention: Short inter-pregnancy interval (<24 months)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Age over 30 years at first birth
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Non-use of modern contraceptive
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Duration of breastfeeding for less than 12 months
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Parity above four
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Unintended pregnancy
Number of subjects: 496
Study: 32553790

Group type: EXPERIMENTAL
Intervention: Combination postoperative radiotherapy (PORT) and androgen deprivation therapy (ADT)
Number of subjects: 502
Study: 36206874

Group type: EXPERIMENTAL
Intervention: Affective touch (slow/soft brushing)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Nonaffective touch (fast brushing)
Number of subjects: 122

Group type: COMPARATOR
Intervention: No touch
Number of subjects: 122
Study: 34479619

Group type: EXPERIMENTAL
Intervention: Anyu Peibo Capsule (1.6 g per day for 8 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32541288

Group type: EXPERIMENTAL
Intervention: Elective labor induction at 39 weeks of gestation
Number of subjects: 1201

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 1201
Study: 34599693

Group type: EXPERIMENTAL
Intervention: WBVE ? OGTT
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: OGTT ? WBVE
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: WBVE
Number of subjects: 18

Group type: COMPARATOR
Intervention: OGTT-alone
Number of subjects: 18
Study: 34189814

Group type: EXPERIMENTAL
Intervention: Radiomics signatures
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Radiomics signature
Number of subjects: 895

Group type: COMPARATOR
Intervention: Hematoma volume
Number of subjects: 895
Study: 32182387

Group type: COMPARATOR
Intervention: Topical ketoconazole 2% cream twice daily and placebo (GI)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Topical 0.1% adapalene gel twice daily and placebo (GII)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Topical combination of 0.1% adapalene gel (at night) and ketoconazole 2% cream (in the morning) (GIII)
Number of subjects: 90
Study: 35015037

Group type: EXPERIMENTAL
Intervention: Once-weekly subcutaneous semaglutide, 2.4 mg
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Once-daily subcutaneous liraglutide, 3.0 mg
Number of subjects: 338

Group type: COMPARATOR
Intervention: Pooled placebo
Number of subjects: 338
Study: 32081690

Group type: EXPERIMENTAL
Intervention: CO2 laser-assisted blepharoplasty (initial incision with CO2 laser at 3 W, remaining steps at 9 W)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Scalpel-assisted blepharoplasty (initial incision with scalpel, remaining steps with CO2 laser at 9 W)
Number of subjects: 21
Study: 32556276

Group type: EXPERIMENTAL
Intervention: Antiparasitic treatment (specifics not provided)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Cysts larger than 14 mm
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Cysts with edema at baseline
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: More than 24 months with seizures
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Mild antibody response
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Increased dose albendazole regime
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Lower doses of dexamethasone
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Not receiving early antiparasitic retreatment
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Complete cure
Number of subjects: 220
Study: 36443792

Group type: EXPERIMENTAL
Intervention: P-ETP (plasma endotrophin)
Number of subjects: 3531

Group type: EXPERIMENTAL
Intervention: U-ETP (urine endotrophin)
Number of subjects: 3531

Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment
Number of subjects: 3531
Study: 34160288

Group type: EXPERIMENTAL
Intervention: 20 IU·kg body wt-1 rHuEPO injections every second day for 3 weeks at sea level
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Altitude exposure (2,320 m)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Concurrent rHuEPO treatment and altitude exposure
Number of subjects: 39

Group type: COMPARATOR
Intervention: Altitude exposure alone
Number of subjects: 39
Study: 33210604

Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (300 mg)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Magnesium-vitamin B6 supplementation (300 mg magnesium + 30 mg vitamin B6)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Magnesium alone
Number of subjects: 264
Study: 34755426

Group type: EXPERIMENTAL
Intervention: Spironolactone treatment
Number of subjects: 1767

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 1767
Study: 33880781

Group type: EXPERIMENTAL
Intervention: Semiparametric proportional rate function models
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cox regression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recurrent event analyses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time-to-first-event analyses
Number of subjects: 0